[1] |
Brand NR, Qu LG, Chao A, et al. Delays and barriers to cancer care in low- and middle-income countries: a systematic review[J]. Oncologist, 2019, 24(12): e1371-e1380. DOI: 10.1634/theoncologist.2019-0057.
|
[2] |
Wu S, Li W, Zhang Q, et al. Comparison of complications between peripheral arm ports and central chest ports: a meta-analysis[J]. J Adv Nurs, 2018, 74(11): 2484-2496. DOI: 10.1111/jan.13766.
pmid: 29917252
|
[3] |
Terra Branco M, de Araujo Brito Buttros D, Carvalho-Pessoa E, et al. Atherosclerotic disease and cardiovascular risk factors in postmenopausal breast cancer survivors: a case-control study[J]. Climacteric, 2019, 22(2): 202-207. DOI: 10.1080/13697137.2018.1551345.
pmid: 30624095
|
[4] |
Zhang MM, Yang YJ, Su D, et al. A randomized controlled trial of a guided self-disclosure intervention to facilitate benefit finding in Chinese breast cancer patients: study protocol[J]. J Adv Nurs, 2019, 75(8): 1805-1814. DOI: 10.1111/jan.14042.
|
[5] |
Yang X, Wu HX, Xiong C, et al. Comprehensive bioinformatics analysis of CYB561 expression in breast cancer: link between prognosis and immune infiltration[J]. BIOCELL, 2023, 47(5): 1021-1037. DOI: 10.32604/biocell.2023.027103.
|
[6] |
Selvi A, Thilagamani S. Scale invariant feature transform with crow optimization for breast cancer detection[J]. Intell Autom Soft Comput, 2023, 36(3): 2973-2987. DOI: 10.32604/iasc.2022.029850.
|
[7] |
林燕, 宋雨, 徐颖, 等. 简化老年综合评估分级在老年女性乳腺癌患者中的应用价值[J]. 中国医学科学院学报, 2021, 43(3): 395-401. DOI: 10.3881/j.issn.1000-503X.13752.
|
[8] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2011版)[J]. 中国癌症杂志, 2011, 21(5): 367-417. DOI: 10.3969/j.issn.1007-3639.2011.05.010.
|
[9] |
李君, 王兴华, 刘学改. 中老年乳腺癌化疗患者自我效能感与心理状态的关系及相关因素探讨[J]. 河南医学研究, 2022, 31(3): 478-481. DOI: 10.3969/j.issn.1004-437X.2022.03.025.
|
[10] |
Jaehoon S, Matthew FL, Iowis Z, et al. Antigen-dependent indu-cible T-cell reporter system for PET imaging of breast cancer and glioblastoma[J]. J Nucl Med, 2023, 64(1): 137-144. DOI: 10.2967/jnumed.122.264284.
|
[11] |
苏闪闪, 郑蔚, 康婷婷, 等. 康复期老年乳腺癌患者疏离感现状及影响因素分析[J]. 解放军护理杂志, 2021, 38(8): 34-37. DOI: 10.3969/ji.ssn.1008-9993.2021.08.010.
|
[12] |
Pani N, Sahu P, Swain D, et al. Effects of fentanyl and dexmedetomidine as adjuvants to bupivacaine in paravertebral block for postoperative analgesia in patients undergoing modified radical mastectomy: aprospective randomised double-blind study[J]. Indian J Anaesth, 2022, 66(Suppl 4): S193-S199. DOI: 10.33545/26643766.2021.v4.i1c.268.
|
[13] |
Mohamed SA, Abdel-Ghaffar HS, Hassan NA, et al. Pharmacokine-tics and pharmacodynamics of 3 doses of oral-mucosal dexmedetomidine gel for sedative premedication in women undergoing modified radical mastectomy for breast cancer[J]. Anesth Analg, 2021, 132(2): 456-464. DOI: 10.1213/ANE.0000000000005108.
|
[14] |
Battisti NML, McCartney A, Biganzoli L. The conundrum of the association of chemotherapy with survival outcomes among elderly patients with curable luminal breast cancer[J]. JAMA Oncol, 2020, 6(10): 1535-1537. DOI: 10.1001/jamaoncol.2020.2194.
|
[15] |
Overcash J, Ford N, Kress E, et al. Comprehensive geriatric assessment as a versatile tool to enhance the care of the older person diagnosed with cancer[J]. Geriatrics (Basel), 2019, 4(2): 39. DOI: 10.3390/geriatrics4020039.
|
[16] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
[17] |
Tamirisa N, Lin H, Shen Y, et al. Association of chemotherapy with survival in elderly patients with multiple comorbidities and estrogen receptor-positive, node-positive breast cancer[J]. JAMA Oncol, 2020, 6(10): 1548-1554. DOI: 10.1001/jamaoncol.2020.2388.
|
[18] |
Abedi A, Adelson J, Androudi S, et al. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990—2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1250-1284. DOI: 10.1016/S0140-6736(20)30750-9.
|
[19] |
Savard MF, Clemons M, Hutton B, et al. De-escalating adjuvant therapies in older patients with lower risk estrogen receptorpositive breast cancer treated with breast-conserving surgery: a systematic review and meta-analysis[J]. Cancer Treat Rev, 2021, 99: 102254. DOI: 10.1016/j.ctrv.2021.102254.
|
[20] |
Wan Q, Su L, Ouyang T, et al. Comparison of survival after breast conserving therapy vs mastectomy among patients with or without the BRCA1/2 variant in a large series of unselected Chinese patients with breast cancer[J]. JAMA Netw Open, 2021, 4(4): e216259. DOI: 10.3747/co.20.1543.
|
[21] |
Mamtani A, Sevilimedu V, Le T, et al. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?[J]. Cancer, 2022, 128(3): 471-478. DOI: 10.1002/cncr.33929.
|